Safety and Efficacy of Combination Therapy with Insulin Glargine and Oral Hypoglycaemic Agents Including DPP-4 Inhibitors in Japanese T2DM Patients: ALOHA 2 Study, a Post-Marketing Surveillance for Lantus®
Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50567#.VESoPlfHRK0 Author(s) Masayuki Kobayashi , Shoko Tsukube , Yukio Ikeda , Yujin Shuto Affiliation(s) Sanofi K.K., Tokyo, Japan . Sanofi K.K., Tokyo, Japanc . ABSTRACT Aims: In the Add-on Lantus ® to Oral Hypoglycaemic Agents 2 (ALOHA 2) Study in Japanese adults with type 2 diabetes mellitus (T2DM), data on the safety and efficacy of combination therapy with insulin glargine (Lantus ® ) and oral anti-hyperglycaemic drugs (OADs) including dipeptidyl peptidase-4 (DPP-4) inhibitors in a real-life setting were collected and analyzed. Methods: This postmarketing surveillance was a prospective, observational, 24-week study that complied with the pharmaceutical ...